Skip to main content

Advertisement

SpringerLink
Log in

Etanercept treatment in patients with rheumatoid arthritis on dialysis

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nakamura M, Sakemi T, Nagasawa K (1999) Severe pancytopenia caused by a single administration of low dose methotrexate in a patient undergoing hemodialysis. J Rheumatol 26:1424–1425

    CAS  PubMed  Google Scholar 

  2. Sin R, Cuchacovich R, Huang W, Espinoza LR (2002) Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis. J Rheumatol 29:636–637

    Google Scholar 

  3. Yee AM, Pochapin MB (2001) Treatment of sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27–31

    CAS  PubMed  Google Scholar 

  4. Ortis-Santamaria V, Valls-Roc M, Sanmari M, Olive A (2003) Anti-TNF treatment in secondary amyloidosis. Rheumatology 42:1425–1426

    Article  Google Scholar 

  5. Hammoudeh M (2006) Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis. Rheumatology 45:357–359

    Article  CAS  PubMed  Google Scholar 

  6. Sugioka Y, Inui K, Koike T (2008) Use of etanercept in a patient with rheumatoid arthritis on hemodialysis. Mod Rheumatol 18:293–295

    Article  PubMed  Google Scholar 

  7. Lee H, Kimko HC, Rogge M, Wang D, Nestorov I, Peck CC (2003) Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis. Clin Pharmacol Ther 73:348–365

    Article  CAS  PubMed  Google Scholar 

  8. Don BR, Spin G, Nestorov I, Hutmacher M, Rose A, Kaysen GA (2005) The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. J Pharm Pharmacol 57:1407–1413

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest statement

None.

Author information

Authors and Affiliations

  1. Section of Medicine and Rheumatology, Kumamoto Center For Arthritis and Rheumatology, 1-15-7 Kuhonji, Kumamoto, 862-0976, Japan

    Tadashi Nakamura & Syu-ichi Higashi

  2. Orthopaedics and Rheumatology, Kumamoto Center For Arthritis and Rheumatology, 1-15-7 Kuhonji, Kumamoto, 862-0976, Japan

    Kunihiko Tomoda & Michishi Tsukano

  3. Section of Nephrology, Kumamoto Chuo Hospital, 1-5-1 Tainoshima, Kumamoto, 862-0965, Japan

    Kenzi Arizono

  4. Nakamura Clinic, 4-3-16 Kengun, Kumamoto, 862-0911, Japan

    Takamichi Nakamura

Authors
  1. Tadashi Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Syu-ichi Higashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kunihiko Tomoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michishi Tsukano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenzi Arizono
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takamichi Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tadashi Nakamura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamura, T., Higashi, Si., Tomoda, K. et al. Etanercept treatment in patients with rheumatoid arthritis on dialysis. Rheumatol Int 30, 1527–1528 (2010). https://doi.org/10.1007/s00296-010-1452-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1452-z

Keywords

Search

Navigation